NASDAQ : IRD
Opus Genetics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.67 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 305.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Opus Genetics, Inc. (IRD) reported revenue of 9.86M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 9.86M | 14.20M | 10.99M | 19.05M | 39.85M | 589.00K |
| Cost of Revenue | 38.62M | 30.81M | 26.85M | 17.65M | 14.36M | 15.17M |
| Gross Profit | -28.77M | -16.62M | -15.86M | 1.40M | 25.50M | -14.58M |
| Selling, General & Admin | 21.84M | 21.98M | 18.21M | 11.96M | 7.27M | 8.12M |
| Operating Expenses | 21.84M | 21.98M | 18.21M | 11.96M | 7.27M | 8.12M |
| Operating Income | -50.61M | -38.60M | -34.07M | -10.56M | 18.23M | -22.70M |
| Interest Expense | -1.57M | -1.47M | -1.33M | -9.00K | -2.00K | |
| Interest & Investment Income | 1.80M | 1.30M | 2.00M | 1.80M | 159.00K | 4.00K |
| Currency Exchange Gain (Loss) | -3.00K | |||||
| Other Non Operating Income (Expenses) | -57.23M | -10.82M | 2.56M | 151.00K | -33.83M | |
| EBT Excluding Unusual Items | -107.61M | -49.59M | -29.52M | -9.94M | 18.37M | -56.53M |
| Gain (Loss) on Sale of Investments | -2.00K | -2.00K | -13.00K | -34.00K | -170.00K | -70.00K |
| Other Unusual Items | -91.00K | |||||
| Pretax Income | -107.61M | -49.59M | -57.53M | -9.97M | 18.20M | -56.69M |
| Income Tax Expense | 12.00K | 315.00K | ||||
| Net Income | -107.61M | -49.59M | -57.53M | -9.99M | 17.89M | -56.69M |
| Net Income to Common | -107.61M | -49.59M | -57.53M | -9.99M | 17.89M | -56.69M |
| Shares Outstanding (Basic) | 83.47M | 62.22M | 26.72M | 21.59M | 19.93M | 14.85M |
| Shares Outstanding (Diluted) | 83.47M | 62.22M | 26.72M | 21.59M | 20.60M | 14.85M |
| EPS (Basic) | -1.29 | -0.80 | -2.15 | -0.46 | 0.90 | -3.82 |
| EPS (Diluted) | -1.29 | -0.80 | -2.15 | -0.46 | 0.87 | -3.82 |
| Free Cash Flow | -40.67M | -35.25M | -25.58M | -1.11M | 14.31M | -19.47M |
| Free Cash Flow Per Share | -0.49 | -0.57 | -0.96 | -0.05 | 0.69 | -1.31 |
| Gross Margin | -291.85% | -117.05% | -144.28% | 7.33% | 63.98% | |
| Operating Margin | -513.47% | -271.90% | -309.99% | -55.45% | 45.74% | -3,854.84% |
| Profit Margin | -1,091.82% | -349.33% | -523.40% | -52.42% | 44.89% | -9,625.30% |
| Free Cash Flow Margin | -412.61% | -248.33% | -232.68% | -5.84% | 35.92% | -3,305.60% |
| EBITDA | -50.55M | -38.55M | -34.06M | -10.56M | 18.23M | -22.70M |
| EBITDA Margin | -271.53% | -55.42% | 45.75% | |||
| D&A For EBITDA | 53.00K | 53.00K | 10.00K | 6.00K | 4.00K | 4.00K |
| EBIT | -50.61M | -38.60M | -34.07M | -10.56M | 18.23M | -22.70M |
| EBIT Margin | -271.90% | -55.45% | 45.74% | |||
| Effective Tax Rate | 1.73% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 88.81M | 45.09M | 30.32M | 50.50M | 42.63M | 24.53M |
| Short-Term Investments | 2.00K | 15.00K | 49.00K | 219.00K | ||
| Cash & Short-Term Investments | 88.81M | 45.09M | 30.32M | 50.52M | 42.68M | 24.75M |
| Accounts Receivable | 1.46M | 3.17M | 5.77M | 2.33M | 4.85M | |
| Receivables | 1.46M | 3.17M | 5.77M | 2.33M | 4.85M | |
| Prepaid Expenses | 2.43M | 1.79M | 515.00K | 1.10M | 1.37M | 1.24M |
| Other Current Assets | 80.00K | 71.00K | ||||
| Total Current Assets | 92.70M | 50.04M | 36.61M | 53.95M | 48.99M | 26.07M |
| Property, Plant & Equipment | 172.00K | 199.00K | 252.00K | 6.00K | 10.00K | |
| Total Assets | 92.97M | 50.24M | 36.86M | 53.95M | 48.99M | 26.08M |
| Accounts Payable | 1.88M | 3.29M | 3.15M | 2.15M | 1.07M | 1.58M |
| Accrued Expenses | 5.70M | 4.47M | 7.54M | 1.81M | 1.37M | 1.73M |
| Short-Term Debt | 538.00K | |||||
| Current Income Taxes Payable | 315.00K | |||||
| Other Current Liabilities | 21.00K | 15.00K | 606.00K | 74.00K | ||
| Total Current Liabilities | 7.61M | 7.78M | 11.29M | 4.04M | 2.75M | 3.85M |
| Long-Term Debt | 36.20M | 1.13M | ||||
| Other Long-Term Liabilities | 62.15M | 25.98M | ||||
| Total Liabilities | 105.95M | 34.90M | 11.29M | 4.04M | 2.75M | 3.85M |
| Common Stock | 8.00K | 7.00K | 3.00K | 2.00K | 2.00K | 2.00K |
| Additional Paid-In Capital | 249.23M | 203.93M | 145.72M | 131.37M | 117.72M | 111.59M |
| Retained Earnings | -262.22M | -188.59M | -139.00M | -81.47M | -71.48M | -89.37M |
| Total Common Equity | -12.99M | 15.35M | 6.72M | 49.91M | 46.24M | 22.22M |
| Shareholders' Equity | -12.99M | 15.35M | 25.57M | 49.91M | 46.24M | 22.22M |
| Total Liabilities & Equity | 92.97M | 50.24M | 36.86M | 53.95M | 48.99M | 26.08M |
| Total Debt | 36.20M | 1.13M | 538.00K | |||
| Net Cash (Debt) | 52.61M | 43.96M | 30.32M | 50.52M | 42.68M | 24.21M |
| Net Cash Per Share | 0.63 | 0.71 | 1.14 | 2.34 | 2.07 | 1.63 |
| Filing Date Shares Outstanding | 83.20M | 71.15M | 45.48M | 24.81M | 20.95M | 18.99M |
| Total Common Shares Outstanding | 82.65M | 69.89M | 31.57M | 23.98M | 20.86M | 18.85M |
| Working Capital | 85.09M | 42.26M | 25.32M | 49.91M | 46.23M | 22.21M |
| Book Value Per Share | -0.16 | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 |
| Tangible Book Value | -12.99M | 15.35M | 6.72M | 49.91M | 46.24M | 22.22M |
| Tangible Book Value Per Share | -0.16 | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 |
| Machinery | 25.00K | 25.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -107.61M | -49.59M | -57.53M | -9.99M | 17.89M | -56.69M |
| Depreciation & Amortization | 53.00K | 53.00K | 10.00K | 6.00K | 4.00K | 4.00K |
| Asset Writedown & Restructuring Costs | 28.00M | |||||
| Loss (Gain) From Sale of Investments | 2.00K | 13.00K | 34.00K | 170.00K | 70.00K | |
| Stock-Based Compensation | 4.46M | 3.40M | 3.36M | 3.51M | 1.81M | 1.91M |
| Other Operating Activities | 60.59M | 13.04M | -2.52M | 1.25M | 35.15M | |
| Change in Accounts Receivable | 3.12M | 2.61M | -3.44M | 2.52M | -4.85M | |
| Change in Accounts Payable | 298.00K | 7.00K | 220.00K | 1.08M | -515.00K | 381.00K |
| Change in Other Net Operating Assets | -1.58M | -4.77M | 6.31M | 477.00K | -190.00K | -200.00K |
| Operating Cash Flow | -40.67M | -35.25M | -25.58M | -1.11M | 14.31M | -19.37M |
| Capital Expenditures | -100.00K | |||||
| Other Investing Activities | 1.21M | |||||
| Investing Cash Flow | 1.21M | -100.00K | ||||
| Short-Term Debt Issued | 646.00K | |||||
| Long-Term Debt Issued | 1.00M | |||||
| Total Debt Issued | 35.00M | 1.00M | 646.00K | |||
| Short-Term Debt Repaid | -538.00K | -108.00K | ||||
| Total Debt Repaid | -538.00K | -108.00K | ||||
| Net Debt Issued (Repaid) | 35.00M | 1.00M | -538.00K | 538.00K | ||
| Issuance of Common Stock | 39.70M | 35.96M | 4.50M | 9.26M | 4.46M | 28.58M |
| Repurchase of Common Stock | -149.00K | -152.00K | -79.00K | |||
| Other Financing Activities | -2.40M | 13.22M | -232.00K | -278.00K | -131.00K | -1.51M |
| Financing Cash Flow | 97.15M | 50.02M | 4.19M | 8.98M | 3.79M | 27.61M |
| Net Cash Flow | 56.48M | 14.77M | -20.18M | 7.87M | 18.10M | 8.13M |
| Free Cash Flow | -40.67M | -35.25M | -25.58M | -1.11M | 14.31M | -19.47M |
| Free Cash Flow Margin | -412.61% | -248.33% | -232.68% | -5.84% | 35.92% | -3,305.60% |
| Free Cash Flow Per Share | -0.49 | -0.57 | -0.96 | -0.05 | 0.69 | -1.31 |
| Levered Free Cash Flow | -38.56M | -23.77M | -13.53M | 244.12K | 7.64M | -12.29M |
| Unlevered Free Cash Flow | -37.58M | -22.85M | -13.53M | 1.07M | 7.65M | -12.29M |
| Cash Interest Paid | 9.00K | 2.00K | ||||
| Cash Income Tax Paid | 344.00K | |||||
| Change in Working Capital | 1.84M | -2.15M | 3.09M | 4.08M | -5.55M | 181.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 307.82M | 138.62M | 37.57M | 68.14M | 73.45M | 64.53M |
| Enterprise Value | 255.22M | 108.87M | 931.46K | 25.78M | 59.49M | 41.90M |
| Last Close Price | 3.70 | 2.01 | 1.19 | 3.01 | 3.53 | 3.73 |
| PE Ratio | 4.11 | |||||
| Forward PE | 6.02 | 6.02 | 6.02 | 14.07 | ||
| PS Ratio | 31.23 | 9.77 | 3.42 | 3.58 | 1.84 | 109.56 |
| PB Ratio | 9.03 | 1.47 | 1.36 | 1.59 | 2.90 | |
| P/TBV Ratio | 9.03 | 5.59 | 1.36 | 1.59 | 2.90 | |
| P/FCF Ratio | 5.13 | |||||
| P/OCF Ratio | 5.13 | |||||
| EV/Sales Ratio | 25.89 | 7.67 | 0.09 | 1.35 | 1.49 | 71.13 |
| EV/EBITDA Ratio | 3.26 | |||||
| EV/EBIT Ratio | 3.26 | |||||
| EV/FCF Ratio | 4.16 | |||||
| Debt / Equity Ratio | -2.79 | 0.07 | 0.02 | |||
| Net Debt / Equity Ratio | 4.05 | -2.86 | -1.19 | -1.01 | -0.92 | -1.09 |
| Net Debt / EBITDA Ratio | 1.04 | 1.14 | 0.89 | 4.79 | -2.34 | 1.07 |
| Net Debt / FCF Ratio | 1.29 | 1.25 | 1.19 | 45.43 | -2.98 | 1.24 |
| Asset Turnover | 0.15 | 0.33 | 0.24 | 0.37 | 1.06 | 0.03 |
| Quick Ratio | 11.87 | 6.20 | 3.20 | 13.07 | 17.27 | 6.42 |
| Current Ratio | 12.19 | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 |
| Return on Equity (ROE) | -4,796.52% | -242.41% | -152.46% | -20.77% | 52.26% | -1,295.10% |
| Return on Assets (ROA) | -48.06% | -55.39% | -46.90% | -12.83% | 30.35% | -64.86% |
| Return on Invested Capital (ROIC) | -70.88% | 503.67% | ||||
| Return on Capital Employed (ROCE) | -59.30% | -90.90% | -133.30% | -21.20% | 39.40% | -102.20% |
| Earnings Yield | -34.93% | -35.77% | -153.15% | -14.66% | 24.35% | -87.85% |
| FCF Yield | -13.21% | -25.43% | -68.08% | -1.63% | 19.49% | -30.17% |
| Buyback Yield / Dilution | -116.90% | -132.91% | -23.74% | -4.82% | -38.68% | -218.65% |